Terumo to acquire OrganOx for $1.5 billion

Terumo Corporation has entered into a definitive agreement to acquire all outstanding shares of OrganOx Limited, a medical technology company specializing in organ preservation devices, for approximately $1.5 billion.

“The acquisition marks Terumo’s strategic entry into the organ transplantation-related sector—a field with significant unmet medical needs and strong growth potential.”healthquestcapital.com

• 1 source
• healthquestcapital.com| HealthQuest CapitalMay 7, 2024

Summarized from public sources; check the original articles before acting on it.